Table 5 |
||||
|
Fluorescence in situ hybridisation studies comparing primary breast cancers and their matched distant metastases |
||||
| Reference |
n |
Discordance between metastases and primary tumours (percentage) |
Number of HER2-positive primary tumours |
Number of HER2-positive metastases |
|
|
||||
| [23] |
12 |
0 |
12 |
12 |
| [20] |
68 |
7.0 |
2 |
3 |
| [22] |
14 |
0 |
14 |
14 |
| [21] |
18 |
22.2 |
3 |
7 |
| [19] |
17 |
6.0 |
Not available |
Not available |
| This study |
105 |
7.6 |
21 |
20 |
|
|
||||
|
HER2, gene encoding human EGF-like receptor 2. |
||||
|
Tapia et al. Breast Cancer Research 2007 9:R31 doi:10.1186/bcr1676 |
||||
